Abstract
Pulse oximetry screening for critical congenital heart disease in term and late pre-term newborn
Highlights
Neonatal screening for critical congenital heart disease (CCHD) aids in identifying infants for whom early diagnosis and therapy are beneficial
Pulse oximetry screening in term and late preterm neonates is effective for early diagnosis of CCHD
Detection has led to a decline in poor postoperative outcome due to CCHD2,3
Summary
Neonatal screening for critical congenital heart disease (CCHD) aids in identifying infants for whom early diagnosis and therapy are beneficial. Reported prevalence of congenital heart disease (CHD) at birth is 9 per 1000 live births with around 25% being considered critical[1]. Neonates with such unrecognized critical congenital heart disease (CCHD) can manifest with growth retardation, heart failure, cardiovascular collapse, hypoxicischemic encephalopathy and even death. Pulse oximetry is a noninvasive tool used to detect CCHD5,6. American Academy of Pediatrics recommends pulse oximetry screening of newborns in the case of potential CHD7. Neonatal screening for CCHD aids in identifying infants for whom early diagnosis and therapy are beneficial
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
